Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sleep Apnea Syndrome and Incidence of Major Adverse Cardiac and Cerebrovascular Events (MACCEs) After a First Stroke

NCT04399200 is registered in ClinicalTrials.gov with University Hospital, Grenoble as lead sponsor.

NCT NCT04399200
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04399200 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sleep Apnea Syndrome and Incidence of Major Adverse Cardiac and Cerebrovascular Events (MACCEs) After a First Stroke
Lead sponsor
University Hospital, Grenoble
Phase
Observational
Overall status
Recruiting
Start date
July 13, 2020
Completion date
June 1, 2035
Enrollment
1,620 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fragmentation, sleep, sleep apnea syndromes, sleep apnea, central, sleep apnea, obstructive, sleep-disordered breathing, stroke